Related references
Note: Only part of the references are listed.In Situ Separable Nanovaccines with Stealthy Bioadhesive Capability for Durable Cancer Immunotherapy
Liu Yu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)
Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
Pengfei Zhang et al.
MED (2023)
RNA cancer nanomedicine: nanotechnology-mediated RNA therapy
Bijan Emiliano Ferdows et al.
NANOSCALE (2022)
Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages
Xiangang Huang et al.
NATURE PROTOCOLS (2022)
Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
Na Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
The landscape of mRNA nanomedicine
Xiangang Huang et al.
NATURE MEDICINE (2022)
Transforming cold tumors into hot ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy
Yunfei Yi et al.
MATTER (2022)
Immune cell-produced ROS and their impact on tumor growth and metastasis
Kilian B. Kennel et al.
REDOX BIOLOGY (2021)
pH and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics
Lu An et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy
Senlin Li et al.
BIOMATERIALS (2020)
Toll-Like Receptor Agonists and Radiation Therapy Combinations: An Untapped Opportunity to Induce Anticancer Immunity and Improve Tumor control
Richard C. Walshaw et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages
Wenyue Zhang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Tumor-Associated Macrophage Status in Cancer Treatment
Anna Maria Malfitano et al.
CANCERS (2020)
CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity
Austin P. Huffman et al.
JCI INSIGHT (2020)
pH-Sensitive Biomaterials for Drug Delivery
Shijie Zhuo et al.
MOLECULES (2020)
Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8+ T Cells
Cornelia Hutmacher et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Caroline S. Jansen et al.
NATURE (2019)
New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)
Manuel Piechutta et al.
ESMO OPEN (2019)
Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models
Qilong Wang et al.
THERANOSTICS (2019)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
Andre Veillette et al.
TRENDS IN IMMUNOLOGY (2018)
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu et al.
NATURE (2018)
Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy
Xiaoding Xu et al.
SMALL (2018)
Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives
Hossam S. El-Sawy et al.
ACS NANO (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12
Bharti Garg et al.
GASTROENTEROLOGY (2018)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metabolic origins of spatial organization in the tumor microenvironment
Carlos Carmona-Fontaine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Macrophage Immunometabolism: Where Are We (Going)?
Jan Van den Bossche et al.
TRENDS IN IMMUNOLOGY (2017)
The Untold Story of Granzymes in Oncoimmunology: Novel Opportunities with Old Acquaintances
Maykel Arias et al.
TRENDS IN CANCER (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
Novel insights in the regulation and function of macrophages in the tumor microenvironment
Evangelia Bolli et al.
CURRENT OPINION IN ONCOLOGY (2017)
The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
Kiavash Movahedi et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages
Evanna L. Mills et al.
CELL (2016)
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Heleen. H. Van Acker et al.
PHARMACOLOGY & THERAPEUTICS (2016)
TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
Thibaud Spinetti et al.
ONCOIMMUNOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Metabolism and epigenetics: a link cancer cells exploit
Alessandro Carrer et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
ROS-major mediators of extracellular matrix remodeling during tumor progression
Dragana Nikitovic et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Origins of tumor-associated macrophages and neutrophils
Virna Cortez-Retamozo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
T cell Activation Is Driven by an ADP-Dependent Glucokinase Linking Enhanced Glycolysis with Mitochondrial Reactive Oxygen Species Generation
Marcin M. Kaminski et al.
CELL REPORTS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Granzymes in cancer and immunity
S. P. Cullen et al.
CELL DEATH AND DIFFERENTIATION (2010)
Reduction-sensitive polymers and bioconjugates for biomedical applications
Fenghua Meng et al.
BIOMATERIALS (2009)
Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists
Svetlana Hamm et al.
JOURNAL OF IMMUNOTOXICOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Anti-IL-16 therapy reduces CD4+T-cell infiltration and improves paralysis and histopathology of relapsing EAE
DS Skundric et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Share Paper
